Medicare Enrolled
Dr. Gerald Ho, M.D.
Internal Medicine · La Palma, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ho from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ho?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ho
Dr. Gerald Ho is an internal medicine specialist in La Palma, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ho performed 233,428 Medicare services across 5,811 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ho received a total of $9,299 from 43 pharmaceutical and/or device companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in internal medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ho is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 0% volume in CA
$9,299 industry payments
Medicare Practice Summary
Medicare Utilization ↗233,428
Medicare services
Top 0% in CA for internal medicine
5,811
Unique beneficiaries
$11
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~11,671 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Tocilizumab injection (Actemra) | 94,925 | $3 | $6 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
26,600 | $6 | $17 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
24,176 | $15 | $28 |
| Denosumab injection (Prolia/Xgeva) | 18,122 | $18 | $30 |
| Belimumab injection, 10 mg An injection of belimumab, a medication administered at a dose of 10 mg. |
14,738 | $12 | $30 |
| Hyaluronan intra-articular injection, 1 mg An injection of hyaluronan or its derivative into a joint space. This procedure delivers 1 mg of the substance directly into the affected joint. |
13,221 | $8 | $35 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
10,410 | $13 | $51 |
| Rituximab biosimilar injection, 10 mg An injection of rituximab-abbs, a biosimilar medication, administered in a 10 mg dose. |
4,300 | $26 | $77 |
| Rituximab injection, 10 mg Administration of a 10 mg dose of rituximab medication via injection. |
4,000 | $13 | $30 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
3,846 | $0 | $6 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
3,830 | $26 | $87 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
3,095 | $97 | $175 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,344 | $14 | $50 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
1,127 | $25 | $75 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
1,114 | $11 | $35 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
1,086 | $71 | $205 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
1,057 | $55 | $200 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
773 | $1 | $10 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
637 | $26 | $60 |
| X-ray of foot, 2 views An X-ray imaging test of the foot using two different angles to create pictures of the bones and joints. |
608 | $25 | $60 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
565 | $0 | $5 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
482 | $115 | $300 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
442 | $18 | $100 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
321 | $31 | $65 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
268 | $44 | $200 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
210 | $62 | $150 |
| Orthovisc intra-articular injection An injection of hyaluronan or its derivative into a joint space to provide lubrication and cushioning. |
194 | $99 | $603 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
173 | $51 | $121 |
| Hyaluronan injection (Euflexxa) for joint An injection of hyaluronan or its derivative, specifically Euflexxa, administered directly into a joint space. |
161 | $101 | $252 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
145 | $129 | $249 |
| X-ray of lower and sacral spine, 2-3 views An X-ray imaging test that captures 2 to 3 views of the lower back and sacral spine to visualize the bones and joints in this area. |
132 | $36 | $90 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
129 | $31 | $80 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
125 | $136 | $248 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
90 | $6 | $83 |
| X-ray of middle spine, 2 views An X-ray imaging test that produces two views of the middle section of the spine to visualize the bones and joints. |
86 | $28 | $90 |
| Home health plan of care re-certification A physician reviews the patient's status and contacts the home health agency to re-certify the plan of care without the patient being present. |
83 | $35 | $200 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
81 | $60 | $200 |
| Hip X-ray, 2-3 views An X-ray imaging test of the hip joint using two to three different angles to visualize the bones and surrounding structures. |
79 | $43 | $100 |
| Orphenadrine injection, up to 60 mg An injection of orphenadrine citrate administered in a dose of up to 60 milligrams. |
65 | $4 | $20 |
| X-ray of sacroiliac joint, 1-2 views An X-ray imaging test of the joint connecting the lower spine to the hip bone, using one to two images. |
62 | $30 | $75 |
| Trigger point injection, 1-2 muscles A procedure involving the injection of medication into one or two specific muscles to treat trigger points. |
60 | $39 | $115 |
| X-ray of upper spine, 2-3 views An X-ray imaging test of the upper spine using two to three different angles to visualize the bones and structures. |
56 | $34 | $80 |
| Methylprednisolone acetate injection, 80 mg An injection of 80 mg of methylprednisolone acetate, a corticosteroid medication. |
44 | $9 | $15 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
37 | $49 | $230 |
| X-ray of ankle, 2 views An X-ray imaging test of the ankle using two different angles to visualize the bones and joints. |
35 | $30 | $65 |
| Quadrivalent influenza vaccine, cell-culture derived A flu shot containing four strains of influenza virus, produced using cell culture technology rather than eggs. This formulation is free from preservatives and antibiotics. |
35 | $33 | $45 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
35 | $33 | $35 |
| New patient office visit, complex (60-74 min) | 34 | $152 | $300 |
| Chest X-ray, 2 views An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall. |
31 | $29 | $60 |
| Joint fluid aspiration or injection, medium joint Removal of fluid from a medium-sized joint or injection of medication into the joint space. |
30 | $43 | $88 |
| Knee X-ray, 3 views An X-ray imaging test of the knee joint that captures three different angles to evaluate the bones and surrounding structures. |
28 | $37 | $75 |
| Ultrasound-guided fine needle aspiration biopsy, first lesion A biopsy procedure where a thin needle is used to collect tissue samples from a growth, guided by ultrasound imaging. This code applies to the first lesion or mass sampled during the session. |
26 | $97 | $200 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
22 | $145 | $309 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
20 | $100 | $139 |
| Joint fluid aspiration or injection, small joint Removal of fluid from a small joint or injection of medication into a small joint. |
17 | $35 | $70 |
| Injection, methylprednisolone acetate, 40 mg | 16 | $6 | $10 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
27.1% high complexity
70.3% medium
2.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,299
Total received (2018-2024)
Avg $1,328/year across 7 years
Top 10% in CA for internal medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
43
Companies
587
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,299 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,706
2023
$846
2022
$297
2021
$249
2020
$46
2019
$3,137
2018
$3,019
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Amgen Inc.
$478
Novartis Pharmaceuticals Corporation
$443
UCB SA
$402
ABBVIE INC.
$95
ANI Pharmaceuticals, Inc.
$77
PFIZER INC.
$51
Lilly USA, LLC
$34
Alexion Pharmaceuticals, Inc.
$26
Zimmer Biomet Holdings, Inc.
$24
DePuy Synthes Sales Inc.
$23
Gilead Sciences, Inc.
$20
AstraZeneca Pharmaceuticals LP
$19
E.R. Squibb & Sons, L.L.C.
$14
Top 3 companies account for 77.5% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,673
Novartis Pharmaceuticals Corporation
$1,088
PFIZER INC.
$951
Horizon Therapeutics plc
$702
UCB SA
$402
Janssen Biotech, Inc.
$382
Celgene Corporation
$363
E.R. Squibb & Sons, L.L.C.
$356
Radius Health, Inc.
$335
Horizon Pharma plc
$321
AbbVie, Inc.
$266
Lilly USA, LLC
$207
Mallinckrodt LLC
$175
Mallinckrodt Enterprises LLC
$172
ABBVIE INC.
$169
Genentech USA, Inc.
$164
GlaxoSmithKline, LLC.
$158
Merck Sharp & Dohme Corporation
$146
Alexion Pharmaceuticals, Inc.
$141
DePuy Synthes Sales Inc.
$135
GENZYME CORPORATION
$127
UCB, Inc.
$119
FIDIA PHARMA USA INC.
$95
ANI Pharmaceuticals, Inc.
$77
Zimmer Biomet Holdings, Inc.
$72
AstraZeneca Pharmaceuticals LP
$61
West-Ward Pharmaceuticals
$54
Ferring Pharmaceuticals Inc.
$48
MEDEXUS PHARMA, INC.
$46
Gilead Sciences, Inc.
$43
MEDAC PHARMA, INC.
$34
Actelion Pharmaceuticals US, Inc.
$33
Boston Scientific Corporation
$30
Flexion Therapeutics, Inc.
$25
AbbVie Inc.
$22
SANOFI-AVENTIS U.S. LLC
$19
Medtronic USA, Inc.
$17
Sobi, Inc
$15
Orthogenrx Inc.
$13
Hikma Pharmaceuticals USA
$13
Forte Bio-Pharma LLC
$13
Egalet US Inc
$11
Organon LLC
$7
Top 3 companies account for 39.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · Actemra · BENLYSTA · BodyGuardian · COSENTYX · Cimzia · EUFLEXXA · EVENITY · Enbrel · FORTEO · Gel-One Cross-linked Hyaluronate · GenVisc 850 · HYALGAN · Humira · Hymovis · ILARIS · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LYRICA · MOVANTIK · Mitigare · N'VISION · Nalocet · NuDyn · OPSUMIT MACITENTAN · ORENCIA · ORTHOVISC · Otezla · PEAK · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SPRIX · STELARA · STRENSIQ · SYNVISC-ONE · Sports Medicine Product Portfolio · TALTZ · TAVNEOS · Tymlos · VIMOVO · XELJANZ · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 10% for internal medicine in CA.
Geographic Context
Internal medicine physicians within 10 mi
4,648
Per 100K population
146.9
County median income
$113,702
Nearest hospital
LA PALMA INTERCOMMUNITY HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Ho is a mixed practice specialist, with above-average Medicare volume (top 0% in CA), with low-engagement industry engagement in the top 10% of CA peers, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Ho experienced with tocilizumab injection (actemra)?
Based on Medicare claims data, Dr. Ho performed 94,925 tocilizumab injection (actemra) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ho receive payments from pharmaceutical companies?
Yes. Dr. Ho received a total of $9,299 from 43 companies across 587 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ho's costs compare to other internal medicine physicians in La Palma?
Dr. Ho's average Medicare payment per service is $11. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ho) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Internal Medicine Physicians in La Palma
Browse internal medicine physicians in La Palma ranked by procedure volume and transparency data.
Highest volume
Top Internal Medicine Physicians in CA
Internal medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Internal Medicine Physicians in CA
Which CA internal medicine physicians receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology